Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapy
- PMID: 35957898
- PMCID: PMC9360549
- DOI: 10.3389/fonc.2022.972906
Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapy
Abstract
Since tyrosine phosphorylation is reversible and dynamic in vivo, the phosphorylation state of proteins is controlled by the opposing roles of protein tyrosine kinases (PTKs) and protein tyrosine phosphatase (PTPs), both of which perform critical roles in signal transduction. Of these, intracellular non-receptor PTPs (PTPNs), which belong to the largest class I cysteine PTP family, are essential for the regulation of a variety of biological processes, including but not limited to hematopoiesis, inflammatory response, immune system, and glucose homeostasis. Additionally, a substantial amount of PTPNs have been identified to hold crucial roles in tumorigenesis, progression, metastasis, and drug resistance, and inhibitors of PTPNs have promising applications due to striking efficacy in antitumor therapy. Hence, the aim of this review is to summarize the role played by PTPNs, including PTPN1/PTP1B, PTPN2/TC-PTP, PTPN3/PTP-H1, PTPN4/PTPMEG, PTPN6/SHP-1, PTPN9/PTPMEG2, PTPN11/SHP-2, PTPN12/PTP-PEST, PTPN13/PTPL1, PTPN14/PEZ, PTPN18/PTP-HSCF, PTPN22/LYP, and PTPN23/HD-PTP, in human cancer and immunotherapy and to comprehensively describe the molecular pathways in which they are implicated. Given the specific roles of PTPNs, identifying potential regulators of PTPNs is significant for understanding the mechanisms of antitumor therapy. Consequently, this work also provides a review on the role of non-coding RNAs (ncRNAs) in regulating PTPNs in tumorigenesis and progression, which may help us to find effective therapeutic agents for tumor therapy.
Keywords: PTPNs; cancer; circRNAs; immunotherapy; lncRNAs; miRNAs.
Copyright © 2022 Tang, Qi, Zhou and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
The expression patterns and the diagnostic/prognostic roles of PTPN family members in digestive tract cancers.Cancer Cell Int. 2020 Jun 12;20:238. doi: 10.1186/s12935-020-01315-7. eCollection 2020. Cancer Cell Int. 2020. PMID: 32536826 Free PMC article.
-
Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.Biopolymers. 1998;47(3):225-41. doi: 10.1002/(SICI)1097-0282(1998)47:3<225::AID-BIP3>3.0.CO;2-O. Biopolymers. 1998. PMID: 9817026 Review.
-
SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.Mol Cell Biol. 2001 Feb;21(4):1077-88. doi: 10.1128/MCB.21.4.1077-1088.2001. Mol Cell Biol. 2001. PMID: 11158295 Free PMC article.
-
The FERM and PDZ domain-containing protein tyrosine phosphatases, PTPN4 and PTPN3, are both dispensable for T cell receptor signal transduction.PLoS One. 2008;3(12):e4014. doi: 10.1371/journal.pone.0004014. Epub 2008 Dec 24. PLoS One. 2008. PMID: 19107198 Free PMC article.
-
TC-PTP and PTP1B: Regulating JAK-STAT signaling, controlling lymphoid malignancies.Cytokine. 2016 Jun;82:52-7. doi: 10.1016/j.cyto.2015.12.025. Epub 2016 Jan 23. Cytokine. 2016. PMID: 26817397 Review.
Cited by
-
PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review.Int J Mol Sci. 2022 Sep 2;23(17):10025. doi: 10.3390/ijms231710025. Int J Mol Sci. 2022. PMID: 36077422 Free PMC article. Review.
-
PTPN1 is a prognostic biomarker related to cancer immunity and drug sensitivity: from pan-cancer analysis to validation in breast cancer.Front Immunol. 2023 Oct 23;14:1232047. doi: 10.3389/fimmu.2023.1232047. eCollection 2023. Front Immunol. 2023. PMID: 37936713 Free PMC article.
-
Distinctive genes and signaling pathways associated with type 2 diabetes-related periodontitis: Preliminary study.PLoS One. 2024 Jan 19;19(1):e0296925. doi: 10.1371/journal.pone.0296925. eCollection 2024. PLoS One. 2024. PMID: 38241313 Free PMC article.
-
PTPN2 inhibits TG-induced ERS-initiated TNBC apoptosis through the mitochondrial pathway.Sci Rep. 2025 Jun 6;15(1):19896. doi: 10.1038/s41598-025-04312-w. Sci Rep. 2025. PMID: 40481083 Free PMC article.
-
Mechanism of action and potential therapeutic targets of TGF-β-related signaling pathway and its downstream miRNA expression in pulmonary arterial hypertension.Front Pharmacol. 2025 Jun 6;16:1596767. doi: 10.3389/fphar.2025.1596767. eCollection 2025. Front Pharmacol. 2025. PMID: 40548051 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous